Migraine: a European health priority
Aldo Patriciello hosted a webinar lead by EMHA inside the context of the Yearly European Migraine Day to expose the socio-economic burden of Migraine, its challenges and difficulties to diagnose and to treat as well as a Call to Action with political recommendations.
The document proposes a series of recommendations for the European Commission, the European Parliament and national governments.
For more information, Download the Call to Action Document here.
The European Migraine & Headache Alliance is a non-profit association of patients, that works as an umbrella of different patient groups around Europe.
The Alliance was launched in 2006 and since then, we represent more than 30 patient groups across the continent.
EMHA is an active member of the European Federation of Neurological Alliances [EFNA], the International Association of Patient Organizations [IAPO], the European Patients Forum [EPF] and also works closely with different organizations such as the European Headache Federation [EHF], European Brain Council [EBC] among others.
EMHA is the result of the need of making society be more aware of the importance of headache disorders which currently are not receiving the importance they deserve. Therefore, EMHA organizes and is present in activities and events relevant for headache issues, trying to give voice for those ones who need it.
EMHA also work in partnership with the research world, in finding ways to mitigate migraine, participating actively in congresses, conferences, seminars and roundtables.
Over the last few years a lot has been achieved towards better meeting the needs of those living with migraine and yet more still needs to be done to address the considerable burden of migraine.
In partnership with patient organisations, including the European Migraine and Headache Alliance (EMHA) and funded by Novartis, three resources were developed.
About Migraine & Headaches
Headache disorders are among the most common disorders of the nervous system. These include tension-type headache (TTH), migraine and chronic daily headache syndromes as well as the more rare disorders, cluster headache and trigeminal neuralgia.
According to the World Health Organisation (WHO), migraine alone is one of the top ten leading causes of disability and affects 12-15% of the population, which means one in seven suffer a headache disorder. Despite these data, remains under-diagnosed and under-treated throughout Europe.
In order to understand how patients evolve their lives around migraine, EMHA generates evidence with its own studies in collaboration with different associations, organizations and Universities, collecting interesting data.
EMHA advocates for the rights and needs of the 80 million people in Europe living with a headache disorder. Therefore, our aim is to spread and add value to all the work done by different organizations related to migraine patients and advocay groups in Europe, as well as working closely to the scientific world, giving voice and spread the concerns of headache patients across Europe.
Reaching our goal to influence policy makers and the society in general, of the importance of headache disorders.
Aldo Patriciello hosted a webinar lead by EMHA inside the context of the Yearly European Migraine Day to expose the [...]
Women at Work results from Migraine at Work survey. 7 Countries 7 Languages : France, Spain, Germany, Italy, Portugal, UK [...]
Many people think that migraines are just a headache, but for people living with migraines it’s a debilitating condition. EMHA [...]
The Italian senate has approved the recognition of primary chronic headache as a social disease, a huge step towards the [...]
Learn more about migraine, its symptoms, causes, history and key facts.
Check next events at EMHA Calendar
EMHA develops its own projects in collaboration with Neurologist, Universities, Pharma Industry, Patients Associations and Official Institutions, where we work on multiple fields with the aim to bring awareness on migraine and headache disorders.
At the same time, in order to be updated with the latest news and researches, we attend to different national and international conferences, congresses, seminars, organized by medical societies, Pharma industry as well as patient associations, all around the world.